Low RNA translation activit limits the efficacy of hydrodynamic gene transfer to pig liver in vivo

Fecha de publicación:

Autores de IIS La Fe

Grupos

Abstract

Background Hydrodynamic gene delivery has proved an efficient strategy for nonviral gene therapy in the murine liver but it has been less efficient in pigs. The reason for such inefficiency remains unclear. The present study used a surgical strategy to seal the whole pig liver in vivo. Methods A solution of enhanced green fluorescent protein (eGFP) DNA was injected under two different venous injection conditions (anterograde and retrograde), employing flow rates of 10 and 20 ml/s in each case, with the aim of identifying the best gene transfer conditions. The gene delivery and information decoding steps were evaluated by measuring the eGFP DNA, mRNA and protein copy number 24 h after transfection. In addition, gold nanoparticles (diameters of 4 and 15 nm) were retrogradely injected (10 ml/s) to observe, by electron microscopy, the ability of the particle to access the hepatocyte. Results The gene delivery level was higher with anterograde injection, whereas the efficacy of gene expression was better with retrograde injection, suggesting differences in the decoding processes. Thus, retrograde injection mediates gene transcription (mRNA copy/cell) equivalent to that of intermediate expression proteins but the mRNA translation was lower than that of rare proteins. Electron microscopy showed that nanoparticles within the hepatocyte were almost exclusively 4 nm in diameter. Conclusions The results suggest that the low activity of mRNA translation limits the final efficacy of the gene transfer procedure. On the other hand, the gold nanoparticles study suggests that elongated DNA conformation could offer advantages in that the access of 15-nm particles is very limited. Copyright (C) 2014 John Wiley & Sons, Ltd.

Datos de la publicación

ISSN/ISSNe:
1099-498X, 1521-2254

JOURNAL OF GENE MEDICINE  WILEY-BLACKWELL

Tipo:
Article
Páginas:
179-192
Factor de Impacto:
0,808 SCImago
Cuartil:
Q2 SCImago

Citas Recibidas en Web of Science: 9

Documentos

  • No hay documentos

Métricas

Filiaciones mostrar / ocultar

Keywords

  • gene therapy; hydrodynamic; liver; nanoparticle; nonviral; pig

Proyectos asociados

MECANISMOS TRANSCRIPCIONALES IMPLICADOS EN EL HIGADO GRASO NO ALCOHOLICO DE ORIGEN METABOLICO E IATROGENICO: INFLUENCIA DE LA RESISTENCIA A LA INSULINA

Investigador Principal: RAMIRO JOVER ATIENZA

PI10/00194 . INSTITUTO DE SALUD CARLOS III . 2010

CONTRATOS DE TECNICOS DE APOYO A LA INVESTIGACION EN EL SISTEMA NACIONAL DE SALUD

CA12/00052 . INSTITUTO DE SALUD CARLOS III; FUNDACIÓN PARA LA INVESTIGACIÓN DEL HOSPITAL UNIVERSITARIO LA FE DE LA COMUNIDAD VALENCIANA . 2013

PLATAFORMA DE UNIDADES DE INVESTIGACION CLINICA Y ENSAYOS CLINICOS

Investigador Principal: JOSÉ VICENTE CASTELL RIPOLL

PT13/0002/0032 . INSTITUTO DE SALUD CARLOS III; FUNDACIÓN PARA LA INVESTIGACIÓN DEL HOSPITAL UNIVERSITARIO LA FE DE LA COMUNIDAD VALENCIANA . 2014

COMPREHENSIVE, INTEGRATIVE AND GENOMIC APPROACH TO THE UNDERSTANDING AND TREATMENT OF CANCER AND LEUKEMIA.

Investigador Principal: MIGUEL ÁNGEL SANZ ALONSO

PIE13/00046 . INSTITUTO DE SALUD CARLOS III; FUNDACIÓN PARA LA INVESTIGACIÓN DEL HOSPITAL UNIVERSITARIO LA FE DE LA COMUNIDAD VALENCIANA . 2014

ENSAYO CLÍNICO PROSPECTIVO Y RANDOMIZADO SOBRE EL USO DE LA RADIOEMBOLIZACIÓN TRANSARTERIAL CON ITRIO 90 (THERASPHERE®) FRENTE AL TRATAMIENTO HABITUAL (SORAFENIB), EN EL TRATAMIENTO DE PACIENTES CON CARCINOMA HEPATOCELULAR EN ESTADIO AVANZADO Y TROMBOSIS PORTAL ASOCIADA.

Investigador Principal: DANIEL PÉREZ ENGUIX

TS-104

ENSAYO CLINICO PROSPECTIVO, ALEATORIZADO, COMPARATIVO DE LA EFICACIA Y SEGURIDAD DEL LEVOFLOXACINO VERSUS ISONIAZIDA EN EL TRATAMIENTO DE LA INFECCION LATENTE TUBERCULOSA DEL TRANSPLANTE HEPATICO.

Investigador Principal: MARINO BLANES JULIÁ

FLISH-ILT . 2011

Cita

Compartir